Rheumatoid arthritis treatment starts with disease-modifying drugs, not just pain relievers. The goal is to slow or stop the immune system from attacking your joints, and the earlier you begin, the better the outcomes. Most people start with a prescription medication called methotrexate, then add or switch to stronger options if needed. Over-the-counter painkillers, corticosteroids, supplements, and dietary changes can all play supporting roles, but they don’t replace the core therapy that protects your joints from permanent damage.
Methotrexate: The First-Line Treatment
Methotrexate is the standard starting point for nearly everyone diagnosed with RA. It works by dialing down the overactive immune response that causes joint inflammation and damage. You typically take it once a week, either as a pill or a self-injection, alongside a folic acid supplement to reduce side effects like nausea and mouth sores.
Improvement usually begins within 4 to 6 weeks, though it can take several months to see the full effect. When used alone in people with early RA (less than a year since diagnosis), methotrexate achieves remission in up to 50% of patients. For people with longer-standing disease, that number drops to around 30%. Those aren’t bad odds for a single medication, but many people will eventually need to add something else.
Combination Therapy and Remission Rates
Adding a biologic or another advanced medication to methotrexate dramatically improves the chances of getting your disease under control. In clinical trials of early RA, combination therapy pushed remission rates as high as 86%, compared to about 50% with methotrexate alone. One large trial found that 74% of patients on combination treatment reached remission versus 50% on methotrexate by itself. Another showed 48% versus 30%. The pattern is consistent: two drugs working together outperform one.
This is why rheumatologists move relatively quickly to combination therapy if methotrexate alone isn’t producing enough improvement within three to six months. The window for preventing joint erosion is narrow, especially in the first year or two after diagnosis.
Biologic Medications
Biologics are lab-engineered proteins that block specific parts of the immune system driving your inflammation. They’re given by injection or IV infusion, and they represent a major step up in potency from methotrexate alone. There are several classes, each targeting a different immune pathway.
TNF inhibitors are the most commonly prescribed biologics. They block a protein called tumor necrosis factor, a key driver of joint inflammation. Options include adalimumab, etanercept, certolizumab, infliximab, and golimumab. These tend to work fast, with some people noticing improvement in as little as 2 to 4 weeks, though the full benefit can take 3 to 6 months to develop.
Other biologics target different parts of the immune system. Tocilizumab and sarilumab block an inflammatory signal called IL-6 and typically take 4 to 8 weeks to show results. Rituximab depletes a type of immune cell involved in the autoimmune attack, but effects take up to 3 months after infusion. Abatacept interferes with the activation of immune cells and generally shows responses within 3 months. Your rheumatologist will choose among these based on your specific disease characteristics, other health conditions, and how you’ve responded to prior treatments.
JAK Inhibitors
JAK inhibitors are pills that block immune signaling pathways inside your cells. They’re convenient because they’re taken orally rather than injected, and they can work relatively quickly. However, they come with significant safety considerations that have changed how doctors prescribe them.
The FDA now requires its strongest safety warning on JAK inhibitors after a large clinical trial found higher rates of serious heart-related events (heart attack and stroke), blood clots, cancer, and death compared to TNF inhibitors. Lymphomas and lung cancers were observed more frequently in patients taking these drugs. The cancer risk was about 48% higher compared to TNF inhibitors, and the cardiovascular risk was about 33% higher.
Because of these findings, JAK inhibitors are now generally reserved for people who haven’t responded well to, or can’t tolerate, at least one TNF inhibitor. If your doctor recommends one, they’ll weigh your personal risk factors for heart disease and cancer before prescribing.
Corticosteroids for Flares
Corticosteroids like prednisone are powerful anti-inflammatory drugs that can rapidly ease pain and swelling during a flare. They’re not meant for long-term use. At doses of 10 mg per day or higher, side effects increase substantially, including bone thinning, weight gain, blood sugar problems, and increased infection risk. Below 5 mg per day, the harm is considered low for most patients, while the 5 to 10 mg range is a gray area that depends on individual factors.
Current guidelines recommend tapering off corticosteroids as quickly as possible. Your doctor will likely prescribe them as a short bridge while waiting for a slower-acting medication like methotrexate or a biologic to kick in. Stopping abruptly after weeks of use can cause problems because your adrenal glands need time to resume producing their own cortisol, so you’ll follow a gradual dose reduction schedule.
Over-the-Counter Pain Relievers
NSAIDs like ibuprofen and naproxen reduce pain and stiffness but do nothing to stop the underlying joint damage. They’re useful for managing day-to-day symptoms while your disease-modifying therapy takes effect, or during mild flares. Many people with RA use them regularly.
Long-term daily NSAID use carries real risks. These drugs can raise blood pressure and increase the chance of heart attack, stroke, and cardiovascular death. Stomach and intestinal problems are common enough that many RA patients take a stomach-protective medication alongside their NSAID. Kidney stress is another concern with prolonged use. If you’re relying on NSAIDs heavily, that’s usually a sign your underlying RA treatment needs adjustment rather than a reason to keep taking more painkillers.
Omega-3 Supplements
Fish oil is the supplement with the strongest evidence in RA. Out of 20 clinical trials, 16 showed significant improvements in at least two measures of disease activity, including morning stiffness, joint tenderness, joint swelling, and pain intensity. The doses that showed benefit ranged widely, but a typical effective dose in the trials was roughly 2 grams of EPA and 1 to 2 grams of DHA per day, which is considerably more than what most standard fish oil capsules provide (you’d likely need 4 to 6 capsules daily of a concentrated product).
One study also found that fish oil supplementation allowed patients to reduce their NSAID use. That said, omega-3s are a complement to your medications, not a replacement. Not every trial showed benefit, and the improvements, while real, are modest compared to what prescription drugs achieve.
Diet and Lifestyle
A Mediterranean-style diet rich in fish, olive oil, vegetables, fruits, and whole grains has shown measurable reductions in RA disease activity in intervention studies. A randomized crossover trial published in the American Journal of Clinical Nutrition found that an anti-inflammatory diet produced meaningful effects on disease activity scores. Fasting followed by a vegetarian diet and gluten-free vegan diets have also shown benefits in smaller studies, though these are harder to maintain long-term.
No diet will replace medication, but eating patterns that reduce overall inflammation in the body can make a noticeable difference in how you feel day to day. Regular physical activity, adequate sleep, and stress management also affect inflammation levels and joint stiffness, making them worth treating as part of your overall approach rather than afterthoughts.
How Long Before You Feel Better
One of the hardest parts of RA treatment is the waiting. Methotrexate takes 4 to 6 weeks minimum. TNF inhibitors can start working in 2 to 4 weeks but continue improving over 3 to 6 months. Other biologics like rituximab and abatacept may take a full 3 months before you notice a difference. During this gap, your doctor may use corticosteroids or NSAIDs to keep symptoms manageable.
If your first medication doesn’t work well enough, switching or adding a drug is normal, not a failure. Most people try more than one approach before finding the right combination. The key metric your rheumatologist tracks is disease activity, a composite score based on your swollen and tender joints, blood inflammatory markers, and how you rate your own symptoms. The target is remission or, when that’s not achievable, the lowest disease activity possible.